Search Results 251-260 of 17263 for egfr

1. Phase 2/3 Open-Label Trial Of Sibeprenlimab In The Treatment Of Immunoglobulin A Nephropathy - Mayo Clinic

   * eGFR ≥ 20 mL/min/1.73 m2, calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. Exclusion Criteria: * Subjects who ...

2. A Study to Assess the Safety and Tolerability of ADI-PEG 20 Combined with Pemetrexed and Cisplatinin in Subjects with Tumors Requiring Arginine - Mayo Clinic

   ... EGFR mutant or ALK positive must have had an EGFR tyrosine kinase inhibitor or ALK inhibitor (if available); Subjects with HCC must have already failed ...

3. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

   Patients with non-squamous NSCLC histology that have unknown EGFR and/or ALK status require test results at screening. ALK and/or EGFR may be assessed ...

4. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

   ... EGFR mutations targeted by third generation TKIs [e.g., T790M for osimertinib]). NSCLC patients after failure of up to 4 prior treatment regimens containing ...

5. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

   estimated Glomerular Filtration Rate (eGFR) ≥ 60 ml/min by Modification of Diet in Renal Disease criteria;; Alanine aminotransferase (ALT) and aspartate ...

6. A Study to Evaluate Genetic Testing in Guiding Treatment for Patients with Brain Metastases - Mayo Clinic

   For lung cancer, EGFR mutant patients must have failed EGFR therapies; For HER2-positive breast cancer patients, patients must have received at least one ...

7. A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) - Mayo Clinic

   using the Bedside Schwartz [Schwartz and Work, 2009] eGFR formula for age <18). 21. Active liver disease defined as any known current infectious, neoplastic ...

8. Preemptive kidney transplant - Type - Mayo Clinic

   Find out more about preemptive kidney transplant – an alternative to dialysis for treatment of end-stage kidney disease – and what to expect.

9. Research With I-124 EVuzamitide To Elucidate Cardiac AmyLoidosis - Mayo Clinic

   * eGFR less than 15mL/min/1.73m2. * Myocardial infarction within three (3) months of screening. * Has severe claustrophobia or any condition, medial or ...

10. Mayo Clinic Minute: Research shows newer blood thinners have lower risk of kidney function decline

    People with A-fib often have problems with blood clots forming that can lead to strokes. To prevent the clots, health care providers generally prescribe these ...